Multimodal Therapy May be Key to Improving Survival for Octogenarians Undergoing Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: An American Multicenter Analysis
- PMID: 39871074
- DOI: 10.1245/s10434-025-16916-7
Multimodal Therapy May be Key to Improving Survival for Octogenarians Undergoing Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: An American Multicenter Analysis
Abstract
Background: As the population ages, the number of octogenarians with pancreatic ductal adenocarcinoma (PDAC) continues to rise. Morbidity and mortality following pancreatectomy have improved owing to safer surgery and better chemoradiation regimens. This study compares the outcomes and multimodality utilization in octogenarians (≥80 years) who underwent pancreaticoduodenectomy (PD) for PDAC, with a younger cohort.
Methods: This is a multi-institutional retrospective review from 2007 to 2023 of patients who underwent PD for PDAC. Preoperative, perioperative, and oncologic outcomes were analyzed, and multivariable analysis (MVA) was performed.
Results: A total of 1,051 patients underwent PD for PDAC ( ≥ 80 = 125, < 80 = 926). Octogenarians had a higher age unadjusted Charlson Comorbidity Index (p = 0.0146) and were more likely to have prior abdominal surgery (p = 0.0019). Patients <80 years received chemotherapy (p < 0.0001) or radiation (p < 0.0001), including neoadjuvant chemotherapy (p < 0.0001), more frequently than octogenarians, who more commonly underwent upfront surgery (p < 0.0001). There were no significant differences in complications. Octogenarians had a higher 90 day mortality rate (7.2% versus 3.5%, p = 0.0424); however, this was not significant on MVA. The <80 cohort had longer overall survival (OS) (p = 0.0004). Receiving any chemotherapy was associated with longer OS (hazard ratio [HR] 0.59 [0.46-0.75], p < 0.0001). In survival analysis of octogenarians only, receiving multimodal therapy significantly prolonged OS compared with surgery alone (p = 0.0349).
Conclusions: Octogenarian status does not increase morbidity or mortality but is associated with decreased survival in PDAC patients undergoing PD. Chemotherapy had a protective effect on OS; however, octogenarians received less multimodal therapy compared with the younger cohort.
Keywords: Multimodal therapy; Neoadjuvant chemotherapy; Octogenarians; Pancreatic ductal adenocarcinoma; Pancreaticoduodenectomy.
© 2025. Society of Surgical Oncology.
Conflict of interest statement
Disclosure: Dr. Hogg has received funding from Intuitive Surgical, Inc. to the institution for education and training, she serves as a consultant for Olympus Corporation. Dr. Polanco has served as an Intuitive Surgical, Inc. proctor and is a consultant for Medtronic and Iota Biomedical. Dr. Zeh serves on the scientific advisory board for Surgical Safety Technologies. All other authors have no disclosures.
References
-
- Bureau UC. America is getting older. Census.gov. Accessed July 24, 2024. https://www.census.gov/newsroom/press-releases/2023/population-estimates...
-
- Bureau UC. 2023 National population projections tables: main series. Census.gov. Accessed July 24, 2024. https://www.census.gov/data/tables/2023/demo/popproj/2023-summary-tables...
-
- Nations U. Ageing. United Nations. Accessed July 8, 2024. https://www.un.org/en/global-issues/ageing
-
- Global cancer burden growing, amidst mounting need for services. Accessed July 24, 2024. https://www.who.int/news/item/01-02-2024-global-cancer-burden-growing--a...
-
- Pericleous M, Khan SA. Epidemiology of HPB malignancy in the elderly. Eur J Surg Oncol. 2021;47(3 Pt A):503–13. https://doi.org/10.1016/j.ejso.2020.03.222 . - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
